1,000
Participants
Start Date
January 31, 2014
Primary Completion Date
December 31, 2022
Study Completion Date
April 30, 2023
Dofetilide and/or sotalol
This is an observational study of patients receiving Dofetilide and/or sotalol as part of their routine clinical care. Patients receiving either of these medications will be compared with population controls for genetic analysis.
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Mayo Clinic, Rochester
RECRUITING
University of Colorado Hospital, Aurora
RECRUITING
Massachusetts General Hospital, Boston
COMPLETED
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
Mayo Clinic
OTHER
The Cleveland Clinic
OTHER
University of Colorado, Denver
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Massachusetts General Hospital
OTHER